Sources | Names Used |
---|---|
CTRPv2 | alisertib:navitoclax (2:1 mol/mol) |
PharmacoGx | alisertib:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZBED4 | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-12 |
mRNA | ADNP2 | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-11 |
mRNA | RCC2 | CTRPv2 | pan-cancer | AAC | 0.26 | 9e-11 |
mRNA | ZNF766 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-10 |
mRNA | WRN | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-10 |
mRNA | LDOC1L | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-10 |
mRNA | KLHL23 | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-10 |
mRNA | KCNH3 | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-10 |
mRNA | CBX2 | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-10 |
mRNA | ZNF407 | CTRPv2 | pan-cancer | AAC | 0.23 | 9e-10 |